Literature DB >> 8770920

Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene.

M Lu1, C Miller, J F Habener.   

Abstract

The insulin-, glucagon- and somatostatin-producing cells (beta, alpha, and delta, respectively) in the pancreatic islets derive from a common precursor stem cell and differentiate sequentially during embryonic development. The homeodomain protein islet duodenum HOX (IDX)-1 [insulin promoter factor (IPF)-1/somatostatin transactivating factor (STF)-1)] is a transcription factor critically required for both the development of the pancreas and the transcriptional expression of the insulin gene. IDX-1 may also act to determine the differentiation of the common pancreatic precursor to beta, alpha, and delta cells. Although IDX-1 is detected in most adult mouse islet beta-cells and regulates insulin gene transcription, it is also found in 15% of the delta-cells and transactivates the rat somatostatin gene. The roles of different domains of IDX-1 involved in the transactivation of the somatostatin gene are unclear. In this study, we have created a series of amino- and carboxy-terminal deletions, as well as point substitution mutations to delineate functional domains within the IDX-1 protein. We find that deletions amino-proximal to the homeodomain enhance DNA-binding to the TAAT-1 transcriptional control element within the somatostatin gene promoter. However, these amino-terminal deletions result in substantial decreases in transactivation of a transcriptional reporter containing the TAAT-1 element. Paradoxically, coexpression of the transcriptionally inactive, amino-terminally deleted IDX-1 mutant proteins, either with the wild-type IDX-1 or with themselves, results in a marked enhancement of transactivation of the transcriptional TAAT-1 element reporter. We provide evidence that this synergistic enhancement of transactivation is mediated by protein-protein interactions among the regions of IDX-1 located carboxyl-proximal to the homeodomain. Although successive deletions into the carboxy-terminal region do not alter DNA-binding, these deletions result in a biphasic enhancement and diminution of transactivation. The IDX-1 homeodomain mediates sequence- specific DNA-binding because substitution mutations within this region abolish DNA-binding. All of the amino- and carboxy-terminal deletion proteins were present in nuclear extracts of transfected cells, suggesting that nuclear localization signals reside within the IDX-1 homeodomain. The mapping of the functional domains of IDX-1 may facilitate understanding of IDX-1-mediated gene regulation and islet cell development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770920     DOI: 10.1210/endo.137.7.8770920

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription.

Authors:  B Ritz-Laser; B R Gauthier; A Estreicher; A Mamin; T Brun; F Ris; P Salmon; P A Halban; D Trono; J Philippe
Journal:  Diabetologia       Date:  2003-06-03       Impact factor: 10.122

2.  CK2 phosphorylation of Pdx-1 regulates its transcription factor activity.

Authors:  Rui Meng; Faizeh Al-Quobaili; Isabelle Müller; Claudia Götz; Gerald Thiel; Mathias Montenarh
Journal:  Cell Mol Life Sci       Date:  2010-03-26       Impact factor: 9.261

Review 3.  Exploring the role of homeobox and zinc finger proteins in pancreatic cell proliferation, differentiation, and apoptosis.

Authors:  R Urrutia
Journal:  Int J Pancreatol       Date:  1997-08

4.  Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.

Authors:  W M Macfarlane; T M Frayling; S Ellard; J C Evans; L I Allen; M P Bulman; S Ayres; M Shepherd; P Clark; A Millward; A Demaine; T Wilkin; K Docherty; A T Hattersley
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.

Authors:  E H Hani; D A Stoffers; J C Chèvre; E Durand; V Stanojevic; C Dina; J F Habener; P Froguel
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Glucose regulates steady-state levels of PDX1 via the reciprocal actions of GSK3 and AKT kinases.

Authors:  Rohan K Humphrey; Shu-Mei Yu; Luis E Flores; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

Review 7.  A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis.

Authors:  Daniella A Babu; Tye G Deering; Raghavendra G Mirmira
Journal:  Mol Genet Metab       Date:  2007-07-30       Impact factor: 4.797

8.  The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice.

Authors:  Jennifer M Oliver-Krasinski; Margaret T Kasner; Juxiang Yang; Michael F Crutchlow; Anil K Rustgi; Klaus H Kaestner; Doris A Stoffers
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

9.  Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein.

Authors:  D A Stoffers; V Stanojevic; J F Habener
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity.

Authors:  Aihua Liu; Biva M Desai; Doris A Stoffers
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.